PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

NCT00125918 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: tadalafil
DRUG: tadalafil
DRUG: tadalafil
DRUG: tadalafil
DRUG: placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]